Use of Scandinavian Moist Smokeless Tobacco (Snus) and the Risk of Atrial Fibrillation.

Maria-Pia Hergens, Rosaria Galanti, Jenny Hansson, Peeter Fredlund, Anders Ahlbom, Lars Alfredsson, Rino Bellocco, Marie Eriksson, Eleonor I Fransson, Johan Hallqvist, Jan-Håkan Jansson, Anders Knutsson, Nancy Pedersen, Ylva Trolle Lagerros, Per-Olof Östergren, Cecilia Magnusson

Research output: Contribution to journalArticlepeer-review

Abstract

Snus is a smokeless tobacco product, widely used among Swedish men and increasingly so elsewhere. There is debate as to whether snus is an acceptable "harm-reduction" tobacco product. Since snus use delivers a dose of nicotine equivalent to cigarettes, and has been implicated in cardiac arrhythmia because of associations with sudden cardiovascular death, a relation with atrial fibrillation is plausible and important to investigate.
Original languageEnglish
Pages (from-to)872-876
JournalEpidemiology
Volume25
Issue number6
DOIs
Publication statusPublished - 2014

Subject classification (UKÄ)

  • Public Health, Global Health, Social Medicine and Epidemiology

Fingerprint

Dive into the research topics of 'Use of Scandinavian Moist Smokeless Tobacco (Snus) and the Risk of Atrial Fibrillation.'. Together they form a unique fingerprint.

Cite this